a Department of Paediatrics , Dalhousie University, Canadian Centre for Vaccinology, IWK Health Centre , Halifax , Nova Scotia , Canada.
b Division of Communicable Diseases , Health Security and Environment, WHO Regional Office for Europe , Copenhagen Ø , Denmark.
Hum Vaccin Immunother. 2018 Jan 2;14(1):218-224. doi: 10.1080/21645515.2017.1394533. Epub 2017 Nov 29.
Addressing the drivers of vaccine hesitancy and the barriers to vaccine acceptance is a complex but important task. While the percentage of hesitant does vary from country to country and in time few, if any, countries are ever free from this problem. Overcoming hesitancy requires detection, diagnosis and tailored intervention as there is no simple strategy that can address all of the barriers to vaccine acceptance. Immunization program managers and health care workers need to become adept at recognizing and tackling hesitancy in all of its incarnations if high levels of vaccine acceptance are to be achieved but must also actively support immunization acceptors in order to build and support vaccine acceptance resiliency. This paper presents evidence-informed strategies to achieve these goals.
解决疫苗犹豫的驱动因素和疫苗接受的障碍是一项复杂但重要的任务。虽然犹豫的比例因国家和时间而异，但很少有国家能够完全避免这个问题。克服犹豫需要检测、诊断和针对性的干预，因为没有一种简单的策略可以解决所有疫苗接受的障碍。免疫规划管理人员和卫生保健工作者需要熟练地识别和解决所有形式的犹豫，如果要实现高水平的疫苗接受率，但也必须积极支持免疫接受者，以建立和支持疫苗接受的弹性。本文提出了实现这些目标的循证策略。
